We are live on ! Find out more
SONN

Sonnet BioTherapeutics

Delisted

SONN was delisted on the 2nd of December, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$677K +$503K +595 +438%
Vanguard Group
2
Vanguard Group
Pennsylvania
$632K -$32.1K -38 -5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$250K -$158K -187 -41%
Citadel Advisors
4
Citadel Advisors
Florida
$153K +$140K +165 New
Millennium Management
5
Millennium Management
New York
$147K +$134K +158 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$77K +$70.2K +83 New
BlackRock
7
BlackRock
New York
$69K
TSS
8
Two Sigma Securities
New York
$45K +$29.6K +35 +269%
VF
9
Virtu Financial
New York
$42K -$49.1K -58 -56%
CAM
10
Campion Asset Management
Virginia
$34K +$31.3K +37 New
State Street
11
State Street
Massachusetts
$25K +$1.69K +2 +8%
UBS Group
12
UBS Group
Switzerland
$21K +$2.54K +3 +16%
ASN
13
Advisory Services Network
Georgia
$19K
Jane Street
14
Jane Street
New York
$19K +$16.9K +20 New
Northern Trust
15
Northern Trust
Illinois
$16K
IA
16
IFP Advisors
Florida
$13K
RWG
17
Ratio Wealth Group
Colorado
$8.46K +$7.61K +9 New
JP Morgan Chase
18
JP Morgan Chase
New York
$5K +$5.08K +6 New
MSFS
19
Main Street Financial Solutions
Pennsylvania
$4K
HF
20
HRT Financial
New York
$4K +$4.23K +5 New
TRCT
21
Tower Research Capital (TRC)
New York
$2K +$846 +1 +100%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
-$19K -18 Closed
BPA
23
Beacon Pointe Advisors
California
-$7K -7 Closed